Menu

瑞士诺华的地拉罗司纳入医保了吗

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Is Novartis Switzerland included in medical insurance? In 2010, deferasirox dispersible tablets were approved for marketing in China, and were approved for the treatment of chronic iron overload caused by frequent blood transfusions in beta-thalassemia patients aged 2 years and above and chronic iron overload in patients with non-transfusion-dependent thalassemia (NTDT) syndrome aged 10 years and above. In 2019, deferasirox dispersible tablets entered the latest version of the medical insurance catalog through national negotiations.

Deferasirox is currently the only oral iron chelator developed by Novartis. It was approved by the FDA in November 2005 for use in patients 2 years and older with chronic iron overload caused by blood transfusions. Iron chelators are a new type of iron removal treatment based on directional binding of iron ions in the body, effectively increasing iron excretion, reducing iron content in the body and its pathological deposition in various organs. It is currently the only effective drug for the treatment of iron overload.

Deferasirox from Novartis of Switzerland has been on the market in my country for many years and can be reimbursed through medical insurance, which has alleviated the financial pressure on patients to take medication to a certain extent. However, some patients said that even if they are covered by medical insurance, the price of deferasirox in China is still relatively high, and the economic pressure of long-term medication is very high.

We have learned that in addition to domestic Novartis deferasirox, deferasirox is also available in other countries, and the price is much lower than in China. The specification is 400mg*30 tablets, and the price is around 420$. The price may change due to various factors such as exchange rates. If the patient has a heavy financial burden, you may wish to consult the medical companion travel service to learn about the specific purchase method of this version.

Novartis Pharmaceuticals, headquartered in Basel, Switzerland, is a leading multinational company in the global pharmaceutical and consumer health care industries. If you have other questions about purchasing Novartis Switzerland, please consult the medical companion travel service.

Recommended related hot articles: /newsDetail/94006.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。